The Hannibal Clinic Research Center has published potential anti-inflammatory treatment options for COVID-19 in collaboration with Emory University. The review paper, published in The Journal of Pulmonary and Respiratory Science, highlights the approach of combining antiviral medication with high dose anti-inflammatory medication for moderate to severe cases. Clinical trials are currently being designed to research this theory further.
COVID-19 can affect organs other than the lungs. This causes multi-organ failure and sepsis, the body’s life-threatening response to an infection.
The review was conducted by Hannibal Clinic’s Humam Farah, MD, Director of Pulmonology, Research, Sleep Disorder Center and Alpha-1 Center; and Kimber Steinbeck, BSN, RN, Ancillary Services Manager, Clinical Research Coordinator. Also participating in the review was Ruxana Sandikot, Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta GA.
To see the review paper go to https://medwinpublishers.com/OAJPRS/OAJPRS16000S1-001.pdf